Search

1202760
1201004
1195994
393884
209802
Paediatrics Icon Emeritus Professor Maurice Kibel passes away
We mourn the passing away of Emeritus Professor Maurice Kibel , who was associated with SATVI since its establishment in 2001. Professor Kibel was an icon and pioneer in paediatrics in South Africa, establishing the Child Health Unit in the...
Community Engagement
In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...
Accredited UCT Research Centre
The South African Tuberculosis Vaccine Initiative (SATVI) is an accreditated Research Centre of the University of Cape Town.

News

Tuesday, 28 March 2017

SATVI authors Dr Adam Penn-Nicholson, Associate Professor Tom Scriba and Professor Mark Hatherill have published a paper titled "A novel blood test for tuberculosis prevention and treatment" appearing in the January edition of the South African Medical Journal.

Publication Date:
Monday, January 16, 2017 - 09:15

Dr Sara Suliman, Postdoctoral Fellow has departed from SATVI to take up a postdoctoral fellowship at the Brigham and Women's Hospital at Harvard Medical School.

 

Publication Date:
Tuesday, December 13, 2016 - 14:30

We invite applications from suitably qualified candidates for a vacancy as Senior Scientific Officer in the Immunology Laboratory of the South African Tuberculosis Vaccine Initiative. CLOSED

Publication Date:
Friday, December 9, 2016 - 17:15

SATVI authors have published a paper titled "H1:IC31 vaccination is safe and induces long-lived TNF-a+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial" appearing in the Vaccine Journal.

Publication Date:
Tuesday, December 6, 2016 - 08:45

Pages